Scientific Research Sources

The foundation of our editorial content is the scientific literature. We draw from a range of established, authoritative sources to ensure that the information we present reflects the current state of biomedical knowledge.

Our primary research sources include:

  • PubMed and PubMed Central (PMC) — The U.S. National Library of Medicine's comprehensive database of biomedical literature, providing access to millions of peer-reviewed studies, clinical trials, and systematic reviews
  • National Institutes of Health (NIH) — Including specialized institutes such as the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute on Aging (NIA), and the National Center for Complementary and Integrative Health (NCCIH)
  • Centers for Disease Control and Prevention (CDC) — Public health data, epidemiological research, and population-level health statistics
  • Peer-reviewed medical journals — Publications with established editorial review processes, including journals focused on nutrition science, endocrinology, gastroenterology, dermatology, and integrative health
  • Academic and institutional research — Studies conducted by university-affiliated research centers and recognized medical institutions

We do not treat press releases, social media content, or unverified manufacturer claims as primary sources. When such materials are referenced for context, they are identified as such and weighed against independent evidence.

Evaluating Scientific Evidence

Not all research carries equal weight. The scientific community recognizes a hierarchy of evidence, and our editorial process reflects this hierarchy when assessing the strength of findings on any given topic.

  • Systematic reviews and meta-analyses — The highest level of evidence. These studies aggregate and analyze data from multiple independent studies, providing a comprehensive assessment of what the evidence supports. We prioritize these sources when they are available and methodologically sound.
  • Randomized controlled trials (RCTs) — Experimental studies in which participants are randomly assigned to intervention or control groups. Well-designed RCTs with adequate sample sizes provide strong evidence for causal relationships, though individual trials should be interpreted within the context of the broader literature.
  • Observational studies — Cohort, case-control, and cross-sectional studies that identify associations between variables in human populations. These studies are valuable for generating hypotheses and identifying patterns, but they cannot establish causation on their own.
  • Emerging and preclinical research — In vitro studies, animal models, and early-phase human trials that explore biological mechanisms or test preliminary hypotheses. This research is important for scientific progress but carries significant limitations in terms of applicability to general human health.

We consider the position of a finding within this hierarchy when determining how to present it in our content — and we communicate that context to our readers.

Interpreting Health Research

Scientific literacy involves more than citing studies. It requires the ability to interpret findings accurately, acknowledge limitations, and present conclusions in proportion to the evidence that supports them.

Our editorial approach follows several principles when interpreting research:

  • Contextualization — Individual studies are presented within the broader research landscape, not as isolated proof. We describe what the cumulative evidence suggests, noting areas of consensus as well as areas of ongoing debate.
  • Proportional language — We match the certainty of our language to the strength of the evidence. Well-established findings are described with confidence. Preliminary or conflicting evidence is described using language that reflects its provisional nature — such as "research suggests," "early evidence indicates," or "findings are mixed."
  • Transparency about limitations — Every study has limitations, and we believe readers benefit from understanding them. We note relevant factors such as sample size, study duration, population specificity, and potential confounders when they are important for interpretation.
  • No exaggeration — We do not overstate what the evidence supports. If a finding is promising but not yet replicated, we say so. If a mechanism is well-understood in animal models but not yet confirmed in humans, we make that distinction clear.

This approach serves our commitment to accuracy and respects the intelligence of our readers. For more on our editorial standards, see our Editorial Policy.

Limitations of Emerging Research

Health and nutrition science is a dynamic field. New studies are published continuously, and media coverage of early findings can sometimes create impressions that outpace the actual evidence. We take particular care when addressing emerging research.

Key considerations that guide our treatment of new findings:

  • Replication — A single study, regardless of its results, does not constitute scientific consensus. Findings gain credibility when they are independently replicated across different populations, settings, and research teams.
  • Translation from preclinical to clinical — Results observed in cell cultures or animal models do not automatically apply to human health. The transition from preclinical research to validated human outcomes involves multiple stages of investigation, and many promising preclinical findings do not survive this process.
  • Publication bias — Studies with positive or novel results are more likely to be published than those with null findings. This bias can create a skewed impression of the evidence base, and we account for this when evaluating the strength of emerging research.
  • Evolving consensus — What is considered emerging today may become established tomorrow — or may be refuted entirely. We present emerging research as part of an ongoing scientific conversation, not as settled fact.

This measured approach ensures that our readers receive information that is not only current but also appropriately calibrated to the state of the evidence. For more on how we distinguish between educational content and clinical advice, see our Medical Review Policy.

Related Pages